Paul Aisen, MD
Director, Alzheimer's Therapeutic Research InstituteProfessor of Neurology, Keck School of Medicine of USC
An advisory panel of experts convened in 2020 to assess the critical challenges facing recruitment in Alzheimer’s clinical trials and develop a set of recommendations to overcome them.
This paper revisits expert predictions for advances in Alzheimer’s disease made in 2001 and projects future breakthroughs over the next 20 years.
Even modest delays in the progression of Alzheimer’s disease could dramatically alter the current trajectory and generate large health benefits.